Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Kidney International Supplements|January 25, 2019
Diagnosis of diabetic kidney disease: state of the art and future perspectiveFrederik Persson, Peter RossingKidney International|January 3, 2018
YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrologyFrederik Persson, Rikke BorgProteomics. Clinical Applications|January 12, 2019
Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future PerspectivesFrederik Persson, Peter RossingUgeskrift for Laeger|September 14, 2012
[Renal disease by type 2 diabetes]Frederik Persson, Peter RossingAdvances in Chronic Kidney Disease|December 19, 2021
What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?Peter Rossing, Frederik PerssonAdvances in Chronic Kidney Disease|March 8, 2014
Sequential RAAS blockade: is it worth the risk?Frederik Persson, Peter RossingJournal of Nephrology|June 1, 2020
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?Nete Tofte, Frederik Persson, Peter RossingAnnals of Translational Medicine|May 14, 2021
A narrative review of new treatment options for chronic kidney disease in type 2 diabetesFrederik Persson, Rikke Borg, Peter RossingCurrent Opinion in Nephrology and Hypertension|October 11, 2019
Mitigating risk of aldosterone in diabetic kidney diseaseMarie Frimodt-Møller, Frederik Persson, Peter RossingBritish Journal of Clinical Pharmacology|January 3, 2013
Direct renin inhibition in chronic kidney diseaseFrederik Persson, Peter Rossing, Hans-Henrik ParvingPageof 16